Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and Sensitivity and Specificity

fulvestrant has been researched along with Sensitivity and Specificity in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bittner, GD; Stoner, MA; Yang, CZ1
Huang, J; Liang, K; Xiao, Z; Yang, L1
Balaram, VM; Dasandi, B; Parmar, D; Rao, JV; Rathnam, S; Teja, BB1
Altorjai, G; Bartsch, R; Hussian, D; Locker, GJ; Mader, R; Pluschnig, U; Sevelda, U; Steger, GG; Wenzel, C; Zielinski, CC1
Lane, MV; Merchenthaler, I; Shughrue, PJ1
Conover, CA; Harris, SA; Kassem, M; Okazaki, R; Riggs, BL; Spelsberg, TC1
De Arment, R; Demers, L; Fischer, S; Franks, M; Griffith, J; Leiby, B; Manni, A; Mauger, D; Verderame, M; Washington, S1
Annable, T; Collins, KI; Frost, P; Greenberger, LM; Komm, BS; Lyttle, CR; Miller, CP; Satyaswaroop, PG; Zhang, Y1

Trials

1 trial(s) available for fulvestrant and Sensitivity and Specificity

ArticleYear
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
    BMC cancer, 2006, Mar-26, Volume: 6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Disease Progression; Estradiol; Female; Fulvestrant; Humans; Injections, Intramuscular; Middle Aged; Mucin-1; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Treatment Outcome

2006

Other Studies

7 other study(ies) available for fulvestrant and Sensitivity and Specificity

ArticleYear
A robotic BG1Luc reporter assay to detect estrogen receptor agonists.
    Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:5

    Topics: Biological Assay; Cell Line; Estradiol; Estrogen Receptor Antagonists; Estrogens; Fulvestrant; Genes, Reporter; Humans; Luciferases; Reproducibility of Results; Robotics; Sensitivity and Specificity

2014
A bipartite recombinant yeast system for the identification of subtype-selective estrogen receptor ligands.
    Molecular biotechnology, 2009, Volume: 41, Issue:1

    Topics: Analysis of Variance; Biosensing Techniques; Carrier Proteins; Chromatin Immunoprecipitation; Cloning, Molecular; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Ligands; Male; Metallothionein; Recombinant Fusion Proteins; Reproducibility of Results; Saccharomyces cerevisiae; Sensitivity and Specificity; Transcriptional Activation

2009
Sensitive and rapid high-performance liquid chromatography tandem mass spectrometry method for estimation of fulvestrant in rabbit plasma.
    Biomedical chromatography : BMC, 2010, Volume: 24, Issue:8

    Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Estradiol; Fulvestrant; Rabbits; Sensitivity and Specificity; Tandem Mass Spectrometry

2010
Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
    Endocrinology, 1997, Volume: 138, Issue:12

    Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; In Situ Hybridization; Piperidines; Preoptic Area; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Messenger; Sensitivity and Specificity; Tamoxifen; Time Factors

1997
Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor.
    Calcified tissue international, 1998, Volume: 62, Issue:1

    Topics: Bucladesine; Cell Line; Colforsin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Osteoblasts; Polymerase Chain Reaction; Polyunsaturated Alkamides; Progesterone Congeners; Promegestone; Receptors, Estrogen; RNA, Messenger; Sensitivity and Specificity; Time Factors; Up-Regulation

1998
S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells.
    International journal of oncology, 2001, Volume: 19, Issue:2

    Topics: Adenosylmethionine Decarboxylase; Agar; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Collagen; DNA-Binding Proteins; Drug Combinations; Epidermal Growth Factor; Estradiol; Female; Fulvestrant; Humans; Laminin; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Proteoglycans; Sensitivity and Specificity; STAT3 Transcription Factor; Tamoxifen; Trans-Activators; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay

2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: Animals; Binding, Competitive; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Indoles; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Organ Size; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen; Time Factors; Tumor Cells, Cultured; Uterus; Xenograft Model Antitumor Assays

2001